IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembrolizumab new SOC for patients with metastatic #UC. Trial #EV302 displaced 30y Platinum-based combos ⏩ PFS benefit: 12.5 vs 6.3 mo (HR= 0.45) ⏩ OS benefit:

⭐ At Desai Sethi Urology Institute's Urology On The Beach meeting, Rafael Sanchez-Salas of the Division of Urology at McGill University details strategies to emphasize for selecting between focal therapy, active surveillance, and definitive treatments for localized #prostatecancer: buff.ly/4jCgfAp

Outstanding effort by Lara Rodríguez Sánchez #MovingForward Confederación Americana de Urología (CAU) Focal Therapy Society Endourological Society

I’m truly honored to be part of such a great program on #FocalTherapy—Focal Therapy Society in THE 1&only Masterclass. It will be an outstanding gathering! #IPFTSMasterclass25 Imperial Prostate

An essential read for those looking to expand expertise in urethral reconstruction. Huge thanks to Pankaj M Joshi Melanie AP Dr Sanjay Kulkarni Honored to have contributed five chapters. #UrethralReconstruction SIU-Urology Amer. Urol. Assn. USANZ USANZ Training European Association of Urology (EAU)

Fantastic news👏🧡

Review the main advances in #GUoncology from 2024. Explore the proceedings from the 6th #B2BGUCancersTriad Meeting, available now in the latest #SIUJ issue and the #SIUAcademy: bit.ly/4gXX1CD #OpenAccess #SIU2024NewDelhi Peter Black Simon Tanguay Renu Eapen

📣Updated European Association of Urology (EAU) EAU Guidelines on #RenalCellCarcinoma 2025! Read on European Urology 👇 tinyurl.com/ymh3zra7 Full version on European Association of Urology (EAU) 👇 uroweb.org/guidelines/ren… #AxelBex #JensBedke Yasmin Abu-Ghanem Laurence Albiges Umberto Capitanio Saeed Dabestani Milan Hora Tobias Klatte #TeeleKuusk #LarsLund

Andrea Kokorovic MD Girish Kulkarni Fadi Brimo Tony Finelli Armen Aprikian, Luke Lavallee, Fred Saad, Robert Sabbagh, Claudio Jeldres, Jason Izard, Victor McPherson, Nick Power

Rafael Sanchez-Salas talking about IRE and Beyond Focal Therapy Society #aua25 #lasVegas

Ab#4505 ASCO #ASCO25 by Toni Choueiri, MD👉bit.ly/3SML6Oj👉9-year follow up of Checkmate 214 #kidneycancer👉Remarkable improvement in PFS & OS w/ IPI+NIVO in pts w/ RCC, no new safety signals👇#NizarTannir OncoAlert UroToday.com @KidneyCAN Kidney Cancer

#ASCO25 📢 Reflexiones de Brian Rini, MD sobre combinaciones con inmunoterapia en mRCC. @SEOM OncoAlert OncoDaily Uromigos

I am so proud to have graduated from the #UroOncology Clinical and Research Fellowship program McGill University Centre universitaire de santé McGill @McgillDeptSurg Research Institute of the MUHC (The Institute) McGill Genome and being a certified Urologic Oncologist!!🎓 It was thrilling to dive into the clinical, surgical, and research aspects of

Breaking News from ph3 Embark trial👉Enzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #Prostatecancer Congrats to Stephen Freedland, MD neal shore & team! Earlier enza works better! Link👉 rb.gy/iyc3f2 OncoAlert UroToday.com Prostate Cancer Foundation

🚀 Dive into cutting-edge tech, bold debates & hands-on sessions at #SIU2025Edinburgh! 👨‍⚕️ Meet global experts & explore the future of #urology. 📅 Full programme: bit.ly/40TE91Q 🖊️ Register now: bit.ly/3E2ir3Z

Societie International d'Urologie (SIU) is a urological society with more than 17,000 members from over 130 countries globally. This year, the SIU Congress will be held in Edinburgh from 29th October to 1st November. Registration link: siu-urology.org/congress-2025/…

Kidney Cancer Canada & KCRNC announce the Warren Y Soper Kidney Cancer Research $100,000.00 grant opportunity. Applications accepted at : kcrnc.org/research-award… Application deadline is September 26 2025. @kidneycancer_ca #kidneycancer #cancerdurein #research

We are thrilled to announce and welcome Dr Scott Eggener as the new chair of Urology at UCLA Health A thought leader in Amer. Urol. Assn. Society of Urologic Oncology and at UChicago Urology , we look forward to seeing the impact of your leadership here in Los Angeles.

🚨 PROGRAMME ANNOUNCEMENT 🚨 Join world-renowned experts at #SIU2025Edinburgh for the 7th B2B GU Cancers Triad Meeting. Prepare for a dynamic event dedicated to cutting-edge advances in the management of the most prevalent GU malignancies: prostate, bladder, and kidney cancers.

📢 New in European Urology: SABR is not just for brain mets. A systematic review shows excellent results in RCC—alone or with IO. 🧠 Local control in primary RCC 🛡️ Delay of systemic therapy in oligomets ⚡ IO + SABR: promising combos 🔗 buff.ly/5XN3Ejr #RCC #SABR